Aurobindo Subsidiary Gets USFDA Observations for API Plant

Sep 30, 2024 16:40

Aurobindo Pharma's subsidiary, Apitoria Pharma, received 10 observations from the USFDA after an inspection of its API facility in Telangana. The observations are procedural in nature and will be addressed.

New Delhi, Sep 30 (PTI) Aurobindo Pharma on Monday said the US health regulator has issued 10 observations after inspecting the API facility of its subsidiary in Telangana.

The US Food and Drug Administration (USFDA) inspected Unit-II, an active pharmaceutical ingredients (API) manufacturing facility of Apitoria Pharma, a wholly-owned subsidiary of the company, in Sangareddy district from September 23-27, 2024, the Hyderabad-based drug maker said in a regulatory filing.

The inspection closed with 10 observations, it added.

The observations are procedural in nature and will be responded to within the stipulated time, the drug maker stated.

Shares of Aurobindo Pharma on Monday ended 3.16 per cent down at Rs 1,462 apiece on BSE.

Source: PTI

MORE NEWS

Amazon AI Investment to Benefit India Small Biz

Amazon plans $12.7B AI investment in India, aiming to benefit 15M small businesses and...

Mann Holds Roadshow in Osaka, Japan

Punjab CM Bhagwant Mann holds roadshow in Osaka, Japan, attracting Japanese companies...

Ceat to Raise Rs 250 Cr via Securities

Ceat board approves raising up to Rs 250 crore via unsecured non-convertible...

Corona Remedies Raises ₹195 Cr from Anchor...

Corona Remedies raises ₹195 cr from anchor investors before IPO. Public offering...

Sebi Proposes Streamlined FPI Registration

Sebi proposes streamlining FPI registration, introducing abridged applications, and...

Sandip Pradhan Joins Sebi as Whole Time Member

Sandip Pradhan assumes charge as Sebi's Whole Time Member, overseeing market...

Air India & Maldivian Partner for Island Access

Air India partners with Maldivian to offer access to 16 Maldives islands via Male....

BAT Sells Stake in ITC Hotels for Rs 3,856 Cr

British American Tobacco divests 9% stake in ITC Hotels to Abu Dhabi Investment...

RBI Rate Cut: Bankers Expect Further Easing

Bankers anticipate further easing from RBI after recent rate cut to boost GDP growth....

Dabur BSE Nod for Sesa Care Merger

Dabur receives 'no adverse observations' from BSE on its merger with Sesa Care....

Aurobindo Subsidiary Gets USFDA Observations for API Plant

You May Like To Read

MORE NEWS